Related references
Note: Only part of the references are listed.A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
Katrin P. Guillen et al.
NATURE CANCER (2022)
Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids
Johanna F. Dekkers et al.
NATURE PROTOCOLS (2021)
Patient-Derived Explants as a Precision Medicine Patient-Proximal Testing Platform Informing Cancer Management
Abby R. Templeton et al.
FRONTIERS IN ONCOLOGY (2021)
Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery
Ian R. Powley et al.
BRITISH JOURNAL OF CANCER (2020)
Establishment of patient-derived cancer organoids for drug-screening applications
Else Driehuis et al.
NATURE PROTOCOLS (2020)
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
Heidi M. Haikala et al.
NATURE COMMUNICATIONS (2019)
Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma
Yoshimasa Saito et al.
CELL REPORTS (2019)
Cancer modeling meets human organoid technology
David Tuveson et al.
SCIENCE (2019)
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
G. von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance
Alexandra A. Duarte et al.
NATURE METHODS (2018)
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
Norman Sachs et al.
CELL (2018)
Capecitabine Efficacy Is Correlated with TYMP and RB1 Expression in PDX Established from Triple-Negative Breast Cancers
Elisabetta Marangoni et al.
CLINICAL CANCER RESEARCH (2018)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Interrogating open issues in cancer precision medicine with patient-derived xenografts
Annette T. Byrne et al.
NATURE REVIEWS CANCER (2017)
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds
Alejandra Bruna et al.
CELL (2016)
Modeling Development and Disease with Organoids
Hans Clevers
CELL (2016)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
Sylvia F. Boj et al.
CELL (2015)
Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity
Biswanath Majumder et al.
NATURE COMMUNICATIONS (2015)
Patient-derived xenograft models of breast cancer and their predictive power
James R. Whittle et al.
BREAST CANCER RESEARCH (2015)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts
Sergio Y. Alcoser et al.
BMC BIOTECHNOLOGY (2011)
Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models
Anna Bergamaschi et al.
MOLECULAR ONCOLOGY (2009)
A new model of patient tumor-derived breast cancer Xenografts for preclinical assays
Elisabetta Marangoni et al.
CLINICAL CANCER RESEARCH (2007)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Share Paper
